{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:13:50Z","timestamp":1768551230974,"version":"3.49.0"},"reference-count":52,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2018,5,31]]},"DOI":"10.5582\/irdr.2018.01039","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T18:32:22Z","timestamp":1527013942000},"page":"79-86","source":"Crossref","is-referenced-by-count":11,"title":["Current molecular insight to reveal the dynamics of CAG repeating units in spinocerebellar ataxia"],"prefix":"10.5582","volume":"7","author":[{"given":"Priyanka","family":"Vishwakarma","sequence":"first","affiliation":[{"name":"Department of Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasan","family":"Muthuswamy","sequence":"additional","affiliation":[{"name":"Department of Life Science, National Institute of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarita","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moscovich M, Munhoz RP, Teive HA, Raskin S, Carvalho Mde J, Barbosa ER, Ranvaud R, Liu J, L. Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry. 2012; 83:970-974.","DOI":"10.1136\/jnnp-2012-302770"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007; 30:575-621.","DOI":"10.1146\/annurev.neuro.29.051605.113042"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci. 2000; 23:217-247.","DOI":"10.1146\/annurev.neuro.23.1.217"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bastian AJ, Martin TA, Keating JG, Thach WT. Cerebellar ataxia: Abnormal control of interaction torques across multiple joints. J Neurophysiol. 1996; 76:492-509.","DOI":"10.1152\/jn.1996.76.1.492"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bastian AJ. Learning to predict the future: The cerebellum adapts feed forward movement control. Curr Opin Neurobiol. 2006; 16:645-649.","DOI":"10.1016\/j.conb.2006.08.016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vilis T, Hore J. Central neural mechanisms contributing to cerebellar tremor produced by limb perturbations. J Neurophysiol. 1980; 43:279-291.","DOI":"10.1152\/jn.1980.43.2.279"},{"key":"7","unstructured":"7. Harding AE. Clinical features and classification of inherited ataxias. Adv Neurol. 1993; 61:1-14."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matilla-Due\u00f1as A, Ashizawa T, Brice A, <i>et al<\/i>. Consensus paper: Pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum. 2014; 13:269-302.","DOI":"10.1007\/s12311-013-0539-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: Mechanisms of dynamic mutations. Nat Rev Genet. 2005; 6:729-742.","DOI":"10.1038\/nrg1689"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LP, Zoghbi HY. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type1. Nat Genet. 1993; 4:221-226.","DOI":"10.1038\/ng0793-221"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Avila-Figueroa A, Cattie D, Delaney S. A small unstructured nucleic acid disrupts a trinucleotide repeat hairpin. Biochem Biophys Res Commun. 2011; 413:532-536.","DOI":"10.1016\/j.bbrc.2011.08.130"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Menon RP, Nethisinghe S, Faggiano S, Vannocci T, Rezaei H, Pemble S, Sweeney MG, Wood NW, Davis MB, Pastore A, Giunti P. The role of interruptions in polyQ in the pathology of SCA1. PLoS Genet. 2013; 9:e1003648.","DOI":"10.1371\/journal.pgen.1003648"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kaytor MD, Warren ST. Aberrant protein deposition and neurological disease. J Biol Chem. 1999; 274:37507-37510.","DOI":"10.1074\/jbc.274.53.37507"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vel\u00e1zquez-P\u00e9rez L, Rodriguez-Labrada R, Garcia-Rodriguez JC, Almaguer- Mederos LE, Cruz-Mari\u00f1o T, Laffita-Mesa JM. A comprehensive review ofspinocerebellar ataxia type 2 in Cuba. Cerebellum. 2011; 10:184-198.","DOI":"10.1007\/s12311-011-0265-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lastres-Becker I, R\u00fcb U, Auburger G. Spinocerebellar ataxia 2 (SCA2). Cerebellum. 2008; 7:115-124.","DOI":"10.1007\/s12311-008-0019-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Orr HT. Cell biology of spinocerebellar ataxia. J Cell Biol. 2012; 197:167-177.","DOI":"10.1083\/jcb.201105092"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pulst SM, Nechiporuk A, Nechiporuk T, <i>et al<\/i>. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996; 14:269-276.","DOI":"10.1038\/ng1196-269"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Costanzi-Porrini S, Tessarolo D, Abbruzzese C, Liguori M, Ashizawa T, Giacanelli M. An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar. Neurology. 2000; 54:491-493.","DOI":"10.1212\/WNL.54.2.491"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Choudhry S, Mukerji M, Srivastava AK, Jain S, Brahmachari SK. CAG repeat instability at SCA2 locus: Anchoring CAA interruptions and linked single nucleotide polymorphisms. Hum Mol Genet. 2001; 10:2437-2446.","DOI":"10.1093\/hmg\/10.21.2437"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Coutinho P, Andrade C. Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology. 1978; 28:703-709.","DOI":"10.1212\/WNL.28.7.703"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lima L, Coutinho P. Clinical criteria for diagnosis of Machado\u2013Joseph disease: Report of a non-Azorean Portuguese family. Neurology. 1980; 30:319-322.","DOI":"10.1212\/WNL.30.3.319"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ashizawa T, Figueroa KP, Perlman SL, <i>et al<\/i>. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis. 2013; 8:177.","DOI":"10.1186\/1750-1172-8-177"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Klugbauer N, Marais E, Hofmann F. Calcium channel alpha2delta subunits: Differential expression, function, and drug binding. J Bioenerg Biomembr. 2003; 35:639-647.","DOI":"10.1023\/B:JOBB.0000008028.41056.58"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. McKeown L, Robinson P, Jones OT. Molecular basis of inherited calcium channelopathies: Role of mutations in pore-forming subunits. Acta Pharmacol Sin. 2006; 27:799-812.","DOI":"10.1111\/j.1745-7254.2006.00394.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Benton CS, de Silva R, Rutledge SL, Bohlega S, Ashizawa T, Zoghbi HY. Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology. 1998; 51:1081-1086.","DOI":"10.1212\/WNL.51.4.1081"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, Agid Y, Brice A, Mandel JL. Polyglutamine expansion as a pathological epitope in Huntington&apos;s disease and four dominant cerebellar ataxias. Nature. 1995; 378:403-406.","DOI":"10.1038\/378403a0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sopher BL, Ladd PD, Pineda VV, Libby RT, Sunkin SM, Hurley JB, Thienes CP, Gaasterland T, Filippova GN, La Spada AR. CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA. Neuron. 2011; 70:1071-1084.","DOI":"10.1016\/j.neuron.2011.05.027"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol. 2000; 16:521-555.","DOI":"10.1146\/annurev.cellbio.16.1.521"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Schulz JB, Borkert J, Wolf S, <i>et al<\/i>. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.Neuroimage. 2010; 49:158-168.","DOI":"10.1016\/j.neuroimage.2009.07.027"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG Jr, Warren ST, Oostra BA, Nelson DL, Thomas Caskey C. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell. 1991; 67:1047-1058.","DOI":"10.1016\/0092-8674(91)90283-5"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Mahadevan M, Tsilfidis C, Sabourin L, <i>et al<\/i>. Myotonic dystrophy mutation: An unstable CTG repeat in the 3&apos;untranslated region of the gene. Science. 1992; 255:1253-1255.","DOI":"10.1126\/science.1546325"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Puissant H, Malinge MC, Larget-Piet A, Martin D, Chauveau P, Odent S, Plessis G, Parent P, Lemarec B, Larget-Piet L. Molecular analysis of 53 fragile X families with the probe StB12.3. Am J Med Genet. 1994; 53:370-373.","DOI":"10.1002\/ajmg.1320530413"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Campuzano V, Montermini L, Molt\u00f2 MD, <i>et al<\/i>. Friedreich&apos;s ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996; 271:1423-1427.","DOI":"10.1126\/science.271.5254.1423"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35. Warner JP, Barron LH, Goudie D, Kelly K, Dow D, Fitzpatrick DR, Brock DJ. A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet. 1996; 33:1022-1026.","DOI":"10.1136\/jmg.33.12.1022"},{"key":"35","unstructured":"36. Muthuswamy S, Agarwal S, Dalal A. Diagnosis and genetic counseling for Friedreich&apos;s Ataxia: A time for consideration of TP-PCR in an Indian Setup. Hippokratia. 2013; 17:38-41."},{"key":"36","doi-asserted-by":"crossref","unstructured":"37. Guerrini L, Lolli F, Ginestroni A, Belli G, Della Nave R, Tessa C, Foresti S, Cosottini M, Piacentini S, Salvi F, Plasmati R, De Grandis D, Siciliano G, Filla A, Mascalchi M. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Brain. 2004; 127:1785-1795.","DOI":"10.1093\/brain\/awh201"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38. Goel G, Pal PK, Ravishankar S, Venkatasubramanian G, Jayakumar PN, Krishna N, Purushottam M, Saini J, Faruq M, Mukherji M, Jain S. Gray matter volume deficits in spinocerebellar ataxia: An optimized voxel based morphometric study. Parkinsonism Relat Disord. 2011; 17:521-527.","DOI":"10.1016\/j.parkreldis.2011.04.008"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39. Pedroso JL, Barsottini OG. Spinal cord atrophy in spinocerebellar ataxia type 1. Arq Neuropsiquiatr. 2013; 71:977.","DOI":"10.1590\/0004-282X20130187"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40. Oz G, Hutter D, Tk\u00e1c I, Clark HB, Gross MD, Jiang H, Eberly LE, Bushara KO, Gomez CM. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov Disord. 2010; 25:1253-1261.","DOI":"10.1002\/mds.23067"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41. Tur-Kaspa I, Jeelani R, Doraiswamy PM. Preimplantation genetic diagnosis for inherited neurological disorders. Nat Rev Neurol. 2014; 10:417-424.","DOI":"10.1038\/nrneurol.2014.84"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42. de Castilhos RM, Furtado GV, Gheno TC, <i>et al<\/i>. Spinocerebellar ataxias in Brazil--frequencies and modulating effects of related genes. Cerebellum. 2014; 13:17-28.","DOI":"10.1007\/s12311-013-0510-y"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43. Vale J, Bugalho P, Silveira I, Sequeiros J, Guimar\u00e3es J, Coutinho P. Autosomal dominant cerebellar ataxia: Frequency analysis and clinical characterization of 45 families from Portugal. Eur J Neurol. 2010; 17:124-128.","DOI":"10.1111\/j.1468-1331.2009.02757.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44. Sch\u00f6ls L, Amoiridis G, B\u00fcttner T, Przuntek H, Epplen JT, Riess O. Autosomal dominant cerebellar ataxia: Phenotypic differences in genetically defined subtypes? Ann Neurol. 1997; 42:924-932.","DOI":"10.1002\/ana.410420615"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45. Tang B, Liu C, Shen L, Dai H, Pan Q, Jing L, Ouyang S, Xia J. Frequency of SCA1, SCA2, SCA3\/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol. 2000; 57:540-544.","DOI":"10.1001\/archneur.57.4.540"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46. Basri R, Yabe I, Soma H, Sasaki H. Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: A study of 113 Japanese families. J Hum Genet. 2007; 52:848-855.","DOI":"10.1007\/s10038-007-0182-x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47. Polo JM, Calleja J, Combarros O, Berciano J. Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain. 1991; 114(Pt 2):855-866.","DOI":"10.1093\/brain\/114.2.855"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48. Leone M, Bottacchi E, D&apos;Alessandro G, Kustermann S. Hereditary ataxias and paraplegias in Valle d&apos;Aosta, Italy: A study of prevalence and disability. Acta Neurol Scand. 1995; 91:183-187.","DOI":"10.1111\/j.1600-0404.1995.tb00430.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49. Saleem Q, Choudhry S, Mukerji M, Bashyam L, Padma MV, Chakravarthy A, Maheshwari MC, Jain S, Brahmachari SK. Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: High frequency of SCA2 and evidence for a common founder mutation. Hum Genet. 2000; 106:179-187.","DOI":"10.1007\/s004390051026"},{"key":"49","doi-asserted-by":"crossref","unstructured":"50. Orozco G, Estrada R, Perry TL, Ara\u00f1a J, Fernandez R, Gonzalez-Quevedo A, Galarraga J, Hansen S. Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J Neurol Sci. 1989; 93:37-50.","DOI":"10.1016\/0022-510X(89)90159-7"},{"key":"50","doi-asserted-by":"crossref","unstructured":"51. Matsumura R, Futamura N, Ando N, Ueno S. Frequency of spinocerebellar ataxia mutations in the Kinki district of Japan. Acta Neurol Scand. 2003; 107:38-41.","DOI":"10.1034\/j.1600-0404.2003.01347.x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"52. Zhao Y, Tan EK, Law HY, Yoon CS, Wong MC, Ng I. Prevalence and ethnic differences of autosomal-dominant cerebellar ataxia in Singapore. Clin Genet. 2002; 62:478- 481.","DOI":"10.1034\/j.1399-0004.2002.620610.x"},{"key":"52","doi-asserted-by":"crossref","unstructured":"53. van de Warrenburg BP, Sinke RJ, Verschuuren-Bemelmans CC, Scheffer H, Brunt ER, Ippel PF, Maat-Kievit JA, Dooijes D, Notermans NC, Lindhout D, Knoers NV, Kremer HP. Spinocerebellar ataxias in the Netherlands: Prevalence and age at onset variance analysis. Neurology. 2002; 58:702-708.","DOI":"10.1212\/WNL.58.5.702"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/7\/2\/7_2018.01039\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T06:02:48Z","timestamp":1571378568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/7\/2\/7_2018.01039\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2018.01039","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,31]]}}}